NEWS DETAIL

[BCJ] Étude de phase II du zanubrutinib en association avec le protocole R-CHOP pour le traitement du lymphome diffus à grandes cellules B nouvellement diagnostiqué présentant des altérations génétiques spécifiques à l’hôpital du cancer de Fudan – MedSci

【BCJ】复旦肿瘤医院泽布替尼联合R-CHOP治疗携带特定基因改变的初治弥漫大B细胞淋巴瘤的II期研究 梅斯医学 MedSci

Informations médicales

该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Questions frequentes

Which products are related to this article?

No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat